Michael Schroeter

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Therapeutic advances in neurological disorders

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Journal of neurology

Journal of central nervous system disease

This page only lists publications with an associated author ORCID identifier.

Publications

Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel
Guideline for the management of myasthenic syndromes. Therapeutic advances in neurological disorders 16 (2023)
Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel
Guideline for the management of myasthenic syndromes. Therapeutic advances in neurological disorders 16 (2023)
Heinz Wiendl, Angela Abicht, Andrew Chan, Adela Della Marina, Tim Hagenacker, Khosro Hekmat, Sarah Hoffmann, Hans-Stefan Hoffmann, Sebastian Jander, Christian Keller, Alexander Marx, Arthur Melms, Nico Melzer, Wolfgang Müller-Felber, Marc Pawlitzki, Jens-Carsten Rückert, Christiane Schneider-Gold, Benedikt Schoser, Bettina Schreiner, Michael Schroeter, Bettina Schubert, Jörn-Peter Sieb, Fritz Zimprich, Andreas Meisel
Guideline for the management of myasthenic syndromes. Therapeutic advances in neurological disorders 16 (2023)
Bernhard Neumann, Klemens Angstwurm, Christian Dohmen, Philipp Mergenthaler, Siegfried Kohler, Silvia Schönenberger, De-Hyung Lee, Stefan T Gerner, Hagen B Huttner, Andrea Thieme, Andreas Steinbrecher, Juliane Dunkel, Christian Roth, Hauke Schneider, Heinz Reichmann, Hannah Fuhrer, Ingo Kleiter, Christiane Schneider-Gold, Anke Alberty, Jan Zinke, Michael Schroeter, Ralf Linker, Andreas Meisel, Julian Bösel, Henning R Stetefeld, null null
Weaning and extubation failure in myasthenic crisis: a multicenter analysis. Journal of neurology (2023)
Michael Schroeter, Benjamin Berger, Franz Blaes, Tim Hagenacker, Sebastian Jander, Julia Kaiser, Petra Kalischewski, De-Hyung Lee, Tobias Ruck, Ulrike Schara, Peter Urban, Andreas Meisel
A Sum Score to Define Therapy-Refractory Myasthenia Gravis: A German Consensus. Journal of central nervous system disease 13 (2021)
Monika Rabenstein, Sabine Ulrike Vay, Stefan Blaschke, Helene Luise Walter, Anne Ladwig, Gereon Rudolf Fink, Maria Adele Rueger, Michael Schroeter
Crosstalk between stressed brain cells: direct and indirect effects of ischemia and aglycemia on microglia. Journal of neuroinflammation 17 (1) (2020)
Anne Ladwig, Rebecca Rogall, Jörg Hucklenbroich, Antje Willuweit, Michael Schoeneck, Karl-Josef Langen, Gereon R Fink, M Adele Rueger, Michael Schroeter
Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 14 (2) (2018)
Anne Ladwig, Helene Luise Walter, Jörg Hucklenbroich, Antje Willuweit, Karl-Josef Langen, Gereon Rudolph Fink, Maria Adele Rueger, Michael Schroeter
Osteopontin Augments M2 Microglia Response and Separates M1- and M2-Polarized Microglial Activation in Permanent Focal Cerebral Ischemia. Mediators of inflammation 2017 (2017)

Michael Schroeter.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Schroeter